Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children

References

• Barbey JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry 1998; 59:42–48.
   PubMed Web of Science ®Google Scholar
• Waring WS, Gray JA, Graham A. Predictive factors for generalized seizures after deliberate citalopram overdose. Br J Clin Pharmacol 2008; 66:861–865.
   PubMed Web of Science ®Google Scholar
• Personne M, Persson H, Sjoberg E. Citalopram toxicity. Lancet 1997; 350:518–519.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004; 42:277–285.
   PubMed Web of Science ®Google Scholar
• White NC, Litovitz T, Clancy C. Suicidal antidepressant overdoses: A comparative analysis by antidepressant type. J Med Tox 2008; 4:238–250.
   PubMedGoogle Scholar
• Hayes BD, Klein-Schwartz W, Clark RF, Muller AA, Miloradovich JE. Comparison of toxicity of acute overdoses with citalopram and escitalopram. J Emerg Med 2010; 39:44–48.
   PubMed Web of Science ®Google Scholar
• Nelson LS, Erdman AR, Booze LL, Cobaugh DJ, Chyka PA. Woolf AD, . Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol 2007; 45:315–332.
   PubMed Web of Science ®Google Scholar
• Watson WA, Litovitz TL, Rodgers GC, Klein-Schwartz W, Youniss J, Rose SR, . 2002 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Amer J Emerg Med 2003; 24:353–421.
   Google Scholar
• Catalano G, Catalano MC, Epstein MA, Tsambiras PE. QTc interval prolongation associated with citalopram overdose: a case report and literature review. Clin Neuropharmacol 2001; 24:158–162.
   PubMed Web of Science ®Google Scholar
• Engebretsen KM, Harris CR, Wood JE. Cardiotoxicity and late onset seizures with citalopram overdose. J Emerg Med 2003; 25:163–166.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Friberg LE, Duffull SB. Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose. Intensive Care Med 2006; 32:1060–1065.
   PubMed Web of Science ®Google Scholar
• de Gregorio C, Morabito G, Cerrito M, Dattilo G, Oreto G. Citalopram-induced long QT syndrome and torsade de pointes: role for concomitant therapy and disease. Int J Cardiol 2011; 148:226–228.
   PubMed Web of Science ®Google Scholar
• Kanjanauthai S, Kanluen T, Chareonthaitawee P. Citalopram induced torsade de pointes, a rare life threatening side effect. Int J Cardiol 2008; 131:e33–e34.
   PubMed Web of Science ®Google Scholar
• Fayssoil A, Issi J, Guerbaa M, Raynaud JC, Heroguelle V. Torsade de pointes induced by citalopram and amiodarone. Ann Cardiol Angeiol (Paris) 2011; 60:165–168.
   PubMed Web of Science ®Google Scholar
• Aström-Lilja C, Odeberg JM, Ekman E, Hägg S. Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database. Pharmacoepidemiol Drug Saf 2008; 17:587–592.
   PubMed Web of Science ®Google Scholar
• Tarabar AF, Hoffman RS, Nelson L. Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest. J Med Toxicol 2008; 4:101–105.
   PubMedGoogle Scholar
• Meuleman C, Jourdain P, Bellorini M, Sadeg N, Loiret J, Guillard N, . Citalopram and Torsades de Pointes. A case report. Arch Mal Coeur Vaiss 2001; 94:1021–1024.
   PubMedGoogle Scholar
• Kelly CA, Dhaun N, Laing WJ, Stra-chan FE, Good AM, Bateman DN, . Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol Clin Toxicol 2004; 42:67–71.
   PubMed Web of Science ®Google Scholar
• Kelsey JE, Nemeroff CB. Selective serotonin reuptake inhibitors: citalopram. In: Sadock BJ, Sadock VA, eds. Kaplan and Sadock's comprehensive textbook of psychiatry, 7th edn. Philadelphia: Lippincott Williams & Wilkins; 2000: 2435–2438.
   Google Scholar
• Pacher P, Ungvari Z, Nanasi PP, Furst S, Kecskemeti V. Speculations on difference between tricyclic and selective serotonin reuptake inhibitor anti-depressants on their cardiac effects. Is there any? Curr Med Chem 1999; 6:469–480.
   PubMed Web of Science ®Google Scholar
• Hyttel J. Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 1982; 6:277–295.
   PubMed Web of Science ®Google Scholar
• Witchel HJ, Pabbathi VK, Hofmann G, Paul AA, Hancox JC. Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents. FEBS Lett 2002; 512:59–66.
   PubMed Web of Science ®Google Scholar
• Ostrom M, Eriksson A, Thorson J, Spigset O. Fatal overdose with citalopram. Lancet 1996; 348:339–340.
   PubMed Web of Science ®Google Scholar
• Worm K, Dragsholt C, Simonsen K, Kringsholm B. Citalopram concentrations in samples from autopsies and living persons. Int J Legal Med 1998; 111:188–190.
   PubMed Web of Science ®Google Scholar
• Birkett MA, Shinday NM, Kessler EJ, Meyer JS, Ritchie S, Rowlett JK, . Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice. Pharmacol Biochem Behav 2011; 98:544–551.
   PubMed Web of Science ®Google Scholar
• Choi HC, Kim YI, Song HK, Kim JE, Kim DS, Kang TC, . Effects of selective serotonin reuptake inhibitors on GABAergic inhibition in the hippocampus of normal and pilocarpine induced epileptic rats. Brain Res 2010; 1357:131–141.
   PubMed Web of Science ®Google Scholar
• Jarmamillo JE, Marchbanks B, Willis B, Forrester MB. Evaluation of completeness of selected poison control center data fields. J Med Syst 2010; 34:499–507.
   PubMed Web of Science ®Google Scholar